Eugene Vaios, MD, MBA

Duke Cancer Institute
Durham, NC

I am a Chief Resident in the Duke Department of Radiation Oncology and an NIH-funded researcher with a focus on biomarker discovery for treatment-related toxicity and tumor biology in patients with primary and metastatic brain tumors.

Disclosures:

  • Employment: Duke Cancer Institute:Assistant Professor of Radiation Oncology:Employee
  • Compensation: The Lancet: Honoraria-End Date: 12/4/2025 ;Servier Pharmaceuticals: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: To Present ;Glasshouse Health: Consultant, Compensation Payment-End Date: Present
  • Ownership: none
  • Leadership: none

Presentations

Sep 27

2230 - Efficacy and Safety of Fractionated Stereotactic Radiosurgery for the Treatment of Large Intracranial Arteriovenous Malformations
Poster Hall - Exhibit Hall A
03:00pm - 04:00pm ET
Sep 27

2241 - Neurocognitive Outcomes in Patients with Brain Metastases: A Systematic Review of Past Findings and Future Directions
Poster Hall - Exhibit Hall A
03:00pm - 04:00pm ET
Sep 29

1143 - A Blood-based DNA Methylation Signature for Non-invasive Diagnosis and Prediction of Clinical Outcomes in Patients with Glioblastoma Enrolled on the Phase II Randomized VERTU Trial
Room 160
04:05pm - 04:10pm ET